Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Pharming Group N.V. PHARM.AS NL Equity

Euronext Amsterdam+ CompareTear sheet →
Unclassified · FY ends Dec 31
€1.01
+0.00 (+0.40%)
EUR · as of 2026-08-27 · marketstack

Pharming Group N.V. (Euronext Amsterdam: PHARM.AS) closed at €1.01, +0.4%, on 2026-08-27, with a return on equity of 1.1%, a net margin of 0.8% and 3-year sales growth of 22.3%. Institutional ownership, earnings history and filed financials are on the tabs below.

DateEventWhat happened / filerSource
No 8-K or Schedule 13D/G filings on record for PHARM.AS in the collected window (US SEC filers only).

The US-listed sibling PHARPharming Group N.V. carries this company's SEC filing history — the same company, the other listing.

Source: SEC EDGAR (public domain)

Every row is a filed document, checked against its EDGAR index.